Kairos Pharma, LTD. (KAPA)
↓ Download CSVKey ratios (FY2025)
-85.9%
Return on equity
| Metric (FY) | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Operating Income | -$5.57M | -$2.34M | -$1.71M | — |
| Net Income | -$5.45M | -$2.60M | -$1.81M | — |
| EPS (Diluted) | $-0.30 | $-0.23 | $-0.17 | — |
| Total Assets | $6.54M | $5.77M | $965.0K | — |
| Total Liabilities | — | $992.0K | $3.04M | — |
| Shareholders' Equity | $6.34M | $4.78M | -$2.08M | -$1.18M |
| Cash & Equivalents | $4.49M | $1.27M | — | — |
| Operating Cash Flow | -$3.44M | -$3.96M | $81.0K | — |
| Shares Outstanding | 20.82M | 13.74M | 10.56M | — |